Citius Oncology (CTOR) Long-Term Debt Issuances (2023 - 2024)

Citius Oncology's (CTOR) quarterly Long-Term Debt Issuances came in at $325311.0 in Q2 2024, up 62.66% on a QoQ basis from $200000.0 in Q1 2024.

Citius Oncology (CTOR) Long-Term Debt Issuances (2023 - 2024) Analysis & Trends

Citius Oncology (CTOR) has 2 years of Long-Term Debt Issuances data on file, last reported at $325311.0 in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	3.64 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-
10	Citius Oncology	58.02 Mn	58.02 Mn	1.34 Mn	-

Download Data